AbbVie Inc. (ABBV) |
|
77.61 -0.64 (-0.82%)
|
06-19 16:01 |
|
Open: |
78.88 |
Pre. Close: |
78.65 |
|
High:
|
79.2 |
Low:
|
77.01 |
|
Volume:
|
4,413,830 |
Market Cap:
|
114733M |
|
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
78.558 - 79.107 |
79.107 - 79.528 |
|
Low:
|
75.839 - 76.591 |
76.591 - 77.169 |
|
Close:
|
76.585 - 77.598 |
77.598 - 78.375 |
|
Technical analysis |
as of: 2019-06-19 4:28:59 PM |
|
Overall:
|
  |
| Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 91.94 One year: 95.48 |
| Support: |
Support1: 73.81 Support2: 61.41 |
| Resistance: |
Resistance1: 78.72 Resistance2: 81.75 |
| Pivot: |
77.61 |
| Moving Average: |
MA(5): 78.43 MA(20): 78.15
MA(100): 79.44 MA(250): 86.38 |
| MACD: |
MACD(12,26): -0.21 Signal(9): -0.32  |
| Stochastic oscillator: |
%K(14,3): 75.38 %D(3): 73.33 |
| RSI: |
RSI(14): 45.08 |
| 52-week: |
High: 100.23 Low: 73.81 Change(%): -21.0 |
| Average Vol(K): |
3-Month: 511933 10-Days: 411884 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.ABBV has closed below upper band by 49.8%. Bollinger Bands are 41.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to ABBV's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Wed, 19 Jun 2019 13:30:25 Z
Is Abbott Laboratories a Buy?
Tue, 18 Jun 2019 00:29:59 Z
Bayer to Invest 5 Billion Euros in Weedkiller Research
Mon, 17 Jun 2019 23:33:00 Z
J&J's (JNJ) Tremfya Meets Goal in Psoriatic Arthritis Study
Mon, 17 Jun 2019 23:32:52 Z
AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know
Mon, 17 Jun 2019 21:29:43 Z
Novartis (NVS) Announces Promising Data on Tasigna & Hyrimoz
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Drug Manufacturers - Major |
| Shares Out. (M) |
1478.33 |
| Shares Float (M) |
1476.79 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
|
|
Shares Short (K)
|
27576 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
7.910 |
|
EPS Est. Current Year
|
5.530 |
|
EPS Est. Next Year
|
6.560 |
|
EPS Est. Next Quarter
|
1.440 |
|
Forward EPS
|
8.888 |
|
Book Value (p.s.)
|
39.310 |
|
PEG Ratio
|
1.16 |
|
Profit Margin
|
16.68 |
|
Operating Margin
|
37.13 |
|
Return on Assets (ttm)
|
8.9 |
|
Return on Equity (ttm)
|
-232.3 |
|
Qtrly Rev. Growth
|
-1.3 |
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
-11.70 |
|
Operating Cash Flow (M)
|
13800.00 |
|
Levered Free Cash Flow (M)
|
11140.00 |
Stock Valuations |
|
P/E
|
9.81 |
|
P/E Growth Ratio
|
-0.01 |
|
P/BV
|
1.97 |
|
P/S
|
5325804544.00 |
|
P/CF
|
8.32 |
Dividends & Splits |
|
Dividend
|
5.528 |
|
Dividend Yield
|
0.07 |
|
Dividend Pay Date
|
2019-05-15 |
|
Ex-Dividend Date
|
2019-04-12 |
|
Forward Dividend
|
4.280 |
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
